Skip to main content

Table 2 Haplotypes of CDNF2 in stage 2 patients with SZ

From: Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population

Haplotype Case (freq) Control (freq) Chi square P value Odds ratio (95% CI)
CAGAG 157.87 (0.57) 169.89 (0.50) 2.25 0.13 1.29 (0.94–1.78)
TGATC 45.87 (0.17) 82.00 (0.24) 6.38 0.01 0.61 (0.41–0.92)
TGATG 43.00 (0.16) 57.90 (0.17) 0.30 0.58 0.88 (0.57–1.35)
TGGAG 30.13 (0.11) 26.11 (0.08) 2.61 0.11 1.44 (0.83–2.51)
  1. Significant value has been emphasized by italic
  2. CI confidence interval
\